ARCHIVES

Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants

This article is from The Cancer Letter archive.

Vol. 01 No. 02 | January 10, 1975

Download PDF Visit The Full Archive

Related Articles

Ontak Approved For Lymphoma

October 31, 2008

Prevention Task Force Unable To Reach Consensus On New Division, Tries To Avoid More Disruption

July 6, 1979

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994